Evidence map›Paper›PMID 29399397›Full record

ArticleOncoimmunology

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Elisa Ferretti, Emma Di Carlo, Emanuela Ognio, Giulio Fraternali-Orcioni, Anna Corcione, Beatrice Belmonte, Jean Louis Ravetti, Claudio Tripodo, Domenico Ribatti, Vito Pistoia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Pathogens (Basel, Switzerland) · 2023
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Elisa FerrettiLaboratory of Experimental Therapies in Oncology and Laboratory of Oncology, Istituto Giannina Gaslini, Genova, Italy.
Emma Di CarloDepartment of Medicine and Sciences of Aging, "G. d'Annunzio" University and Ce.SI-MeT, Aging Research Center, Pathological Anatomy and Immuno-Oncology Unit, "G. d'Annunzio" University, Chieti, Italy.
Emanuela OgnioAnimal Facility, IRCCS AOU San Martino - IST - Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Giulio Fraternali-OrcioniUnit of Pathology, IRCCS AOU San Martino - IST - Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Anna CorcioneLaboratorio di Oncologia and Laboratorio malattie autoinfiammatorie e immudeficienze, Istituto Giannina Gaslini, Genova, Italy.
Beatrice BelmonteTumor Immunology Unit, Department of Health Science, Human Pathology Section, University of Palermo, Palermo, Italy.
Jean Louis RavettiUnit of Pathology, IRCCS AOU San Martino - IST - Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Claudio TripodoLaboratorio di Oncologia and Laboratorio malattie autoinfiammatorie e immudeficienze, Istituto Giannina Gaslini, Genova, Italy.
Domenico RibattiDepartment of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy, and National Cancer Institute "Giovanni Paolo II", Bari, Italy.
Vito PistoiaImmunology Research Area, Ospedale Pediatrico Bambino Gesù, Roma, Italy.
Istituto Giannina Gaslini · ITOspedale Policlinico San Martino · ITBambino Gesù Children's Hospital · ITIstituto Tumori Bari · ITUniversity of Chieti-Pescara · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin (IL)-25, a member of the IL-17 cytokine superfamily, is produced by immune and non-immune cells and exerts type 2 pro-inflammatory effects

Indexed as

AngiogenesisB lymphocytesB-NHLCytokinesIL-25Tumor immunology

Identifiers

PMID29399397
PMCPMC5790334
OpenAlexW2766416117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.